 SAN JOSE, Calif., April 5, 2021 PRNewswire -- Anixa Biosciences, Inc. NASDAQ: ANIX, a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, announced today that based on Proof of Concept POC animal study results, it will progress to the next stage of development of its potential anti-viral therapy for Covid-19. 